Gang Hu, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1872 Norwood Dr, 200, Hurst, TX 76054 Phone: 817-540-6060 Fax: 817-553-7994 |
Brian D Ranelle, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1872 Norwood Dr, 200, Hurst, TX 76054 Phone: 817-540-6060 Fax: 817-553-7994 |
Dr. Charley Julius Andrews Iii Iii, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 556 W Bedford Euless Rd, Suite C, Hurst, TX 76053 Phone: 817-283-4688 Fax: 817-540-0736 |
News Archive
RIKEN researchers have developed a promising method to deliver a drug to cancer cells without affecting surrounding tissues, involving a clever combination of an "artificial metalloenzyme" that protects a metal catalyst, and a sugar chain that guides the metalloenzyme to the desired cells.
Many of the medications used to treat children have been developed almost exclusively for adults and approved for them. This is why pediatricians have been demanding for decades that medications be tailored specifically to the needs of the child's body and adequately tested on children. A regulation from the European Commission called the Pediatric Regulation has set out to solve this problem. Clinical studies involving children should ultimately give way to medications tailored for this age group.
Black Americans' covid-19 vaccination rates are still lagging months into the nation's campaign, while Hispanics are closing the gap and Native Americans show the highest rates overall, according to federal data obtained by KHN.
A new study in mice has made a possible breakthrough in Alzheimer's research. The team of researchers at the Cleveland Clinic has noted that deleting a single enzyme can reverse the deposition of harmful plaques in the brains of patients with Alzheimer's disease. This could improve cognitive functions as demonstrated in lab mice. The study appeared this week in the latest issue of the Journal of Experimental Medicine.
European drug companies came out ahead of their U.S. counterparts in making medicines available to people in developing countries, but their lead is beginning to shrink, according to the Access to Medicines Index, released on Monday, Reuters reports (Kelland, 6/21).
› Verified 4 days ago